Whole genome sequencing ( DrugBank: - )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
| 79 | Homozygous familial hypercholesterolemia | 1 |
| 172 | Hypophosphatasia | 1 |
6. Parkinson disease
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05721911 (ClinicalTrials.gov) | June 2023 | 30/1/2023 | Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by iPSC Technology | Implementing a National Biobank of Genetic, Sporadic and Prodromic Parkinson's Disease With Whole Genome Analysis and Functional Assessment of Polygenic Inheritance by iPSC Technology | Parkinson Disease;REM Sleep Behavior Disorder | Genetic: whole genome sequencing | Neuromed IRCCS | NULL | Not yet recruiting | 18 Years | N/A | All | 230 | Italy |
79. Homozygous familial hypercholesterolemia
Clinical trials : 145 / Drugs : 114 - (DrugBank : 26) / Drug target genes : 8 - Drug target pathways : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03234127 (ClinicalTrials.gov) | December 6, 2017 | 26/7/2017 | Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia | Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia | Homozygous Familial Hypercholesterolemia | Genetic: Whole Genome Sequencing | Nantes University Hospital | NULL | Completed | 40 Years | N/A | All | 562 | N/A | France |
172. Hypophosphatasia
Clinical trials : 34 / Drugs : 17 - (DrugBank : 4) / Drug target genes : 3 - Drug target pathways : 6
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05062629 (ClinicalTrials.gov) | August 24, 2021 | 21/9/2021 | United States Hypophosphatasia Molecular Research Center | United States Hypophosphatasia Molecular Research Center | Hypophosphatasia | Genetic: Whole Genome Sequencing | Children's Mercy Hospital Kansas City | NULL | Recruiting | 1 Month | 120 Years | All | 66 | United States |